| AZD6244 and Sorafenib in Advanced Hepatocellular Carcinoma (NCT01029418) | National Cancer Centre, Singapore | 2009-11-01 |
| Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery (NCT01004978) | National Cancer Institute (NCI) | 2009-10-28 |
| A Study to Assess PV-10 Chemoablation of Cancer of the Liver (NCT00986661) | Provectus Biopharmaceuticals, Inc. | 2009-10-01 |
| Effects of Telephone Consultations on Discharged Liver Cancer (NCT01595243) | National Taiwan University Hospital | 2009-10-01 |
| Study of Sunitinib in Patients With Advanced/Inoperable Fibrolamellar Carcinoma (NCT01215565) | Assistance Publique - Hôpitaux de Paris | 2009-10-01 |
| Safety Study of Sorafenib Following Combined Therapy of Radiation and TACE for Liver Cancer (NCT00999843) | Fudan University | 2009-10-01 |
| Immunotherapy of Hepatocellular Carcinoma by Induction of Anti-alpha Fetoprotein Response (NCT01128803) | Nantes University Hospital | 2009-10-01 |
| Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma) (NCT00976170) | Chugai Pharmaceutical | 2009-09-01 |
| A Dose Escalation Trial of Radiation Therapy (RT) for Hepatocellular Carcinoma (HCC) (NCT00960167) | National Taiwan University Hospital | 2009-09-01 |
| Safety and Efficacy of Photodynamic Therapy for Bile Duct Invasion of Hepatocellular Carcinoma (NCT01506115) | Samsung Medical Center | 2009-09-01 |
| Sorafenib With Capecitabine for Patients With Measurable Hepatocellular Carcinoma (NCT01032850) | New Mexico Cancer Research Alliance | 2009-09-01 |
| Trial of TG4023 Combined With Flucytosine in Liver Tumors (NCT00978107) | Transgene | 2009-09-01 |
| Trial of S-1 in Combination With Sorafenib for Patients With Advanced Hepatocellular Carcinoma (NCT01131689) | Samsung Medical Center | 2009-09-01 |
| Non-invasive Prediction of Microvascular Invasion in Hepatocellular Carcinoma by Blood-Oxygen-Level Dependent Magnetic Resonance Imaging (BOLD MRI) (NCT00963612) | University Health Network, Toronto | 2009-09-01 |
| Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver Cancer (NCT01042041) | Abramson Cancer Center at Penn Medicine | 2009-09-01 |
| Stereotaxic Irradiation of Hepatocellular Carcinoma (NCT01165346) | Centre Oscar Lambret | 2009-08-31 |
| Primary Prevention of Patients With Hepatocellular Carcinoma and Concomitant Esophageal Varices (NCT01970748) | Taipei Veterans General Hospital, Taiwan | 2009-08-01 |
| TACE and Adefovir Compared With Transarterial Chemoembolization (TACE) Alone for Hepatitis B Virus (HBV)-Related Unresectable Hepatocellular Carcinoma (HCC) (NCT00960518) | Tongji University | 2009-08-01 |
| Sorafenib With BIIB022 in Hepatocellular Carcinoma (HCC) (NCT00956436) | Biogen | 2009-08-01 |
| Study of Lenvatinib (E7080) in Participants With Advanced Hepatocellular Carcinoma (HCC) (NCT00946153) | Eisai Co., Ltd. | 2009-07-24 |
| Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC (NCT00908752) | Bristol-Myers Squibb | 2009-07-20 |
| Urea Cream Treatment Sorafenib-Associated HSFR in HCC (NCT01934829) | Chinese Anti-Cancer Association | 2009-07-01 |
| 4SC-201 (Resminostat) and Sorafenib in Advanced Hepatocellular Carcinoma (NCT00943449) | 4SC AG | 2009-07-01 |
| Analysis of Expression of Specific Markers in Hepatocellular Carcinoma (NCT00858000) | GlaxoSmithKline | 2009-07-01 |
| Study of Sorafenib In Combination With Low-dose 5-fluorouracil/Cisplatin (FP) Intraarterial Infusion Chemotherapy (NCT00933816) | Kindai University | 2009-07-01 |
| SBRT + TACE for Primary Hepatocellular Carcinoma (NCT00746655) | University of Pittsburgh | 2009-07-01 |
| Study of Sorafenib With Combination of Thalidomide in Hepatocellular Carcinoma (HCC) (NCT00971126) | National Health Research Institutes, Taiwan | 2009-07-01 |
| Trial of Transcatheter Arterial Chemoembolization (TACE) With Sorafenib for Locally Advanced Hepatocellular Carcinoma (HCC) (NCT01170104) | Chung-Ang University | 2009-06-01 |
| Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma (NCT00669136) | Lisa H. Butterfield, Ph.D. | 2009-06-01 |
| Adjuvant Therapy With Thalidomide for Chemoembolization in Advanced Hepatocellular Carcinoma (NCT00921531) | Fudan University | 2009-06-01 |
| A Study of IMC-A12 in Combination With Sorafenib in Participants With Advanced Cancer of the Liver (NCT00906373) | Eli Lilly and Company | 2009-05-01 |
| Comparison of Multiphase and Monophasic Arterial Hepatic MRI in the Detection of Arterial Enhancement of CHC Nodules (NCT04687280) | University Hospital, Angers | 2009-04-22 |
| Microwave Ablation of Resectable Liver Tumors (NCT00892255) | St. Joseph Hospital of Orange | 2009-04-01 |
| Performance of Imaging for the Diagnosis of Small Hepatocellular Carcinoma (< 3 cm)on Cirrhosis (NCT00848952) | University Hospital, Angers | 2009-03-01 |
| Randomized Phase 1/2 Open-Label Trial of PR104 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC) (NCT00862082) | Proacta, Incorporated | 2009-03-01 |
| A Phase 1-2 Study of CF102 in Patients With Advanced Hepatocellular Carcinoma (NCT00790218) | Can-Fite BioPharma | 2009-02-01 |
| A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere® (NCT00877136) | St. Joseph Hospital of Orange | 2009-02-01 |
| Study in Asia of the Combination of TACE With Sorafenib in HCC Patients (NCT00990860) | Taipei Veterans General Hospital, Taiwan | 2009-02-01 |
| Study of Sorafenib and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma (NCT00844883) | Yale University | 2009-02-01 |
| Y-90 Alone or With Sorafenib for Pre-Transplant Hepatocellular Carcinoma (NCT00846131) | Northwestern University | 2009-02-01 |
| Study of Sorafenib, Gemcitabine, and Cisplatin in Advanced Hepatocellular Carcinoma (HCC) (NCT00808145) | Lahey Clinic | 2009-02-01 |
| Long-term Follow-up of HALT-C Sustained Virological Responders (NCT00825877) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2009-01-15 |
| Research on Surgery and Micro-Invasive Treatment in Recurrent Primary Liver Cancer (NCT00822562) | Eastern Hepatobiliary Surgery Hospital | 2009-01-01 |
| Sorafenib and LBH589 in Hepatocellular Carcinoma (HCC) (NCT00823290) | University of Erlangen-Nürnberg Medical School | 2009-01-01 |
| Sonazoid Enhanced Liver Cancer Trial for Early Detection (NCT00822991) | Kindai University | 2009-01-01 |
| Safety Study of ARQ 197 in Cirrhotic Patients With Hepatocellular Carcinoma (HCC) (NCT00802555) | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 2009-01-01 |
| Sorafenib-RT in Treating Hepatocellular Carcinoma (SHEP) (NCT00892658) | University Health Network, Toronto | 2009-01-01 |
| Study of Factors Predicting Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma (HCC) (NCT01198704) | Assistance Publique - Hôpitaux de Paris | 2009-01-01 |
| Total Hemihepatic Vascular Exclusion in Hepatectomy in Hepatocellular Carcinoma Treatment (NCT00827047) | Eastern Hepatobiliary Surgery Hospital | 2009-01-01 |
| Efficacy of Sequential TACE and PVE on the Resectability of Hepatitis B Related HCC (NCT00834158) | Eastern Hepatobiliary Surgery Hospital | 2009-01-01 |
| Role of Positron Emission Tomography in the Evaluation of Response to Sorafenib in Advanced Hepatocellular Carcinoma (NCT01157013) | Hospital Miguel Servet | 2009-01-01 |
| A Trial of Adjuvant Transarterial Chemoembolization (TACE) for Preventing Tumor Recurrence After Liver Resection (NCT00820053) | Eastern Hepatobiliary Surgery Hospital | 2009-01-01 |
| Pringle's Maneuver Versus Selective Hepatic Vascular Exclusion in Hepatectomy (NCT00820339) | Eastern Hepatobiliary Surgery Hospital | 2009-01-01 |
| A Trial of Licartin for Preventing Tumor Recurrence After Liver Resection (NCT00819650) | Eastern Hepatobiliary Surgery Hospital | 2008-12-01 |
| Intraoperative Chemotherapy Against Hepatocellular Carcinoma Recurrence (NCT00817895) | Eastern Hepatobiliary Surgery Hospital | 2008-12-01 |
| Songyou Granule and Transarterial Chemoembolization for Hepatocellular Carcinoma (NCT00805896) | Fudan University | 2008-12-01 |
| Anti-CTLA-4 Human Monoclonal Antibody CP-675,206 in Patients With Advanced Hepatocellular Carcinoma (NCT01008358) | Clinica Universidad de Navarra, Universidad de Navarra | 2008-12-01 |
| Treatment of Portal Vein Tumor Thrombus After Hepatocellular Carcinoma Resection (NCT00825669) | Eastern Hepatobiliary Surgery Hospital | 2008-12-01 |
| The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma (NCT00827554) | Eastern Hepatobiliary Surgery Hospital | 2008-12-01 |
| Hepatectomy Versus Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to Major Blood Vessels (NCT00814242) | Eastern Hepatobiliary Surgery Hospital | 2008-12-01 |
| Impact of Postoperative Adjuvant Chemotherapy in Patients With Hepatocellular Carcinoma After Liver Transplantation (NCT01125020) | Shanghai Jiao Tong University School of Medicine | 2008-12-01 |
| A Trial of Complete Versus Selective HepaticVascular Clamping in Hepatectomy (NCT00851968) | Eastern Hepatobiliary Surgery Hospital | 2008-12-01 |
| Global Study Looking at the Combination of RAD001 and Sorafenib to Treat Patients With Advanced Hepatocellular Carcinoma (NCT00828594) | Novartis Pharmaceuticals | 2008-12-01 |
| Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients (NCT00849264) | Eastern Hepatobiliary Surgery Hospital | 2008-12-01 |
| LC Drug Eluting Bead for Treatment of Liver Cancer Which Cannot be Surgically Removed (NCT00877071) | University of Pittsburgh | 2008-11-01 |
| Cytoreductive Surgery and Transarterial Chemoembolization (TACE) Versus TACE for Hepatocellular Carcinoma (NCT00820157) | Eastern Hepatobiliary Surgery Hospital | 2008-11-01 |
| Analysis of Expression of Specific Markers and Their Prognostic Significance in Hepatocellular Carcinoma (NCT00911196) | GlaxoSmithKline | 2008-11-01 |
| Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001 (NCT00775073) | Gerhard Treiber | 2008-10-01 |
| Transarterial Chemoembolization (TACE) Therapy of Hepatocellular Carcinoma (HCC) With Blocking Tumor Blood Temporarily and Enhancing Perfusion (NCT00826384) | Eastern Hepatobiliary Surgery Hospital | 2008-10-01 |
| Comparison of Microwave and Radiofrequency Ablation for Liver (NCT02539212) | Chinese PLA General Hospital | 2008-10-01 |
| Study of Hepatocellular Carcinoma in Cirrhotic Patients (NCT01904942) | Centre Hospitalier Universitaire Dijon | 2008-10-01 |
| Stereotactic Body Radiotherapy for Liver Tumors (NCT01347333) | Mercy Research | 2008-09-01 |
| Study of Anti-tumour Effects and Safety of Prolarix™ in Hepatocellular Carcinoma (NCT00746590) | BTG International Inc. | 2008-09-01 |
| Study of Sorafenib and Gemcitabine in Advanced Hepatocellular Carcinoma (HCC) (NCT00844688) | Combined Military Hospital, Pakistan | 2008-09-01 |
| Effect of I/R Injuries by Pringle Manoeuvre on the Prognosis of HCC Patients After Curative Hepatectomy (NCT00725335) | Southwest Hospital, China | 2008-09-01 |
| Sorafenib and Transarterial Chemoembolization for Hepatocellular Carcinoma (NCT00768937) | Medical University of Vienna | 2008-09-01 |
| A Study of Changes in Hepatic Function During Radiation Therapy Using Hepatobiliary Single Photon Emission Tomography (SPECT) (NCT01519232) | University of Michigan Rogel Cancer Center | 2008-08-01 |
| A Study of LY2181308 in Patients With Advanced Hepatocellular Carcinoma (NCT00415155) | Eli Lilly and Company | 2008-08-01 |
| Genome-wide Association Study to Predict Treatment Response for Molecular Targeted Therapy in Hepatocellular Carcinoma and Renal Cell Carcinoma (NCT01482520) | Samsung Medical Center | 2008-08-01 |
| A Prospective Randomized Trial Comparing Partial Hepatectomy and TACE Plus PEI for Small Hepatocellular Carcinoma (NCT00825474) | Eastern Hepatobiliary Surgery Hospital | 2008-08-01 |
| Study of TAC-101 as Second Line Treatment in Patients With Advanced Hepatocellular Carcinoma Who Received Sorafenib as First Line Therapy (NCT00687596) | Taiho Oncology, Inc. | 2008-08-01 |
| Efficacy and Safety of Immuncell-LC Group and Non-treatment Group in Hepatocelluar Carcinoma Patients (NCT00699816) | GC Cell Corporation | 2008-07-01 |
| Low-Dose Thalidomide as Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma (NCT00728078) | Sun Yat-sen University | 2008-07-01 |
| Study of SIR-Spheres Plus Sorafenib as 1st Line Treatment for Non-resectable Primary Hepatocellular Carcinoma (HCC) (NCT00712790) | Singapore Clinical Research Institute | 2008-06-01 |
| A Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (NCT00712855) | Human Genome Sciences Inc., a GSK Company | 2008-06-01 |
| Hepatocellular Carcinoma Growth and Molecular Aggressiveness (NCT01657695) | Prof. Facchinetti Fabio | 2008-06-01 |
| Study of Cytokine-induced Killer Cell (CIK) Treatment in Patients After Resection of Liver Cancer (NCT00769106) | Sun Yat-sen University | 2008-06-01 |
| Multi-pronged Ethanol Ablation and Radiofrequency Ablation of Early-stage Hepatocellular Carcinoma (NCT00844454) | Sun Yat-sen University | 2008-05-01 |
| Study of Pegylated Human Recombinant Arginase for Liver Cancer (NCT00988195) | Bio-Cancer Treatment International Limited | 2008-05-01 |
| Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC) (NCT00617981) | Imunon | 2008-05-01 |
| Evaluation of Quality of Life and Survival With MS-20 in Patient With Advanced Hepatocellular Carcinoma (FDA IND 74572) (NCT00707681) | Microbio Co Ltd | 2008-03-01 |
| Immunotherapy of Hepatocellular Carcinoma With Gamma Delta T Cells (NCT00562666) | Rennes University Hospital | 2008-02-01 |
| Risk Factors for the Leakage of Anticancer Drugs to Systemic Circulation by Transcatheter Arterial Chemoembolization (NCT00630240) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2008-02-01 |
| Study of IMC-1121B (Ramucirumab) in Participants With Liver Cancer Who Have Not Previously Been Treated With Chemotherapy (NCT00627042) | Eli Lilly and Company | 2008-02-01 |
| The Efficiency of Postoperative Interferon-alpha Treatment in p48 Positive Patients With Hepatocellular Carcinoma (NCT00838968) | Fudan University | 2008-01-01 |
| A Clinical Study of GP73 as a Hepatocellular Carcinoma (HCC) Tumor Mark (NCT00902902) | Peking Union Medical College Hospital | 2008-01-01 |
| HDE Use Protocol of TheraSphere for Treatment of Unresectable HCC (NCT00605150) | Wake Forest University Health Sciences | 2008-01-01 |
| Evaluation the Possible Influence of Transcatheter Arterial Chemoembolization on Hepatitis B Viral Replication (NCT00769730) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2008-01-01 |
| Long-term Management of Patients With Ruptured HCC (NCT06505291) | University Hospital, Caen | 2008-01-01 |
| Association Between Pre-op Non-Selective Beta-Blockers and Hepatocellular Carcinoma Recurrence Post-Liver Transplant (NCT06233708) | Asan Medical Center | 2008-01-01 |